Abstract:For both in situ or ex situ regeneration of tissues to be repaired,an ideal tissue engineering scaffold should create a local environment to facilitate homing,induced differentiation,and proliferation in addition to its molding function.For a tissue engineering scaffold to achieve this objective,releasing the relevant cell growth factors for sufficient period of time is more efficient and natural over that by material morphology.However,protein drugs are delicate and easily denatured by the harsh conditions of preparation for tissue engineering scaffolds,which may evoke undesirable antibody responses.None of the tissue engineering scaffolds reported to date have achieved long-term sustained-release of cell growth factor proteins in native conformation.To overcome this still-standing hurdle,the present study demonstrated a method to load cytokine proteins into tissue-engineering fibers with preserved native conformation for achieving long term sustained-release.We first preloaded vascular endothelial growth factor (VEGF165) as the model protein into dextran nanoparticles without contacting water-oil or water-gas interface (recognized protein conformation killer) by utilizingthe freezing induced aqueous phase separation method developed in our lab.Then the VEGF165 protected in the matrix of dextran particles were suspended in a solution of poly (lactic-co-glycolic acid) (PLGA) prior to electrospinning to form fibers.In order to avoid burst release in the initial stage by the protein-preloaded particles exposed at the fiber surface,another layer of PLGA fiber which carried no VEGF165 was spanned on the top of the already formed PLGA fiber membrane.A series of physicochemical characterizations comprising scanning electron microscopy (SEM),contact angle,mechanical strength,confirmed that the tissue engineering fibers formed above possessed satisfied surface texture and mechanical strength.The VEGF165 was recovered after each of the preparation step and assayed using CCK-8 test for bioactivity.The results indicated that the VEGF165 recovered from the dextran nanoparticles retained＞97 ％ bioactivity,and that from the final fiber was above 87 ％,both were remarkably higher than that recovered from the fibers formed in which the protein was preloaded in solution form (＜55 ％).In vitro release test showed that nanoparticles composite fibers prepared as above achieved a sustained-release profile with minimal initial burst and un-released residue.The protein was released less than 35 ％ of the total load in the initial five days and over 92％ at day 25.For the fibers wherein VEGF16s was loaded in the solution form,the 53.12 ％ of protein load was released in the initial five days,and 84.52 ％ was released at day 25.The therapeutic efficacy of the VEGF165 loaded fiber membranes were examined on the rat model of lowerlimb ischemia,followed immunohistochemistry observation.The results indicated that the regenerated blood vessels by dextran nanoparticles composite PLGA fibers were significantly more than that by the fibers to which VEGF165 was loaded in solution form.As conclusion,pre-loading proteins in polysaccharide nanoparticles prior to electrospinning was an effective method to prepare efficacious tissue engineere fibers for sustained-release cell growth factored with preserved bioactivity and improved release kinetics.

Sustained release of VEGF by coaxial electrospun dextran/PLGA fibrous membranes in vascular tissue engineering.

Controlled release of PDGF-bb by coaxial electrospun dextran/poly(L- lactide-co-ε-caprolactone) fibers with an ultrafine core/shell structure

Diverse Release Behaviors of Water-Soluble Bioactive Substances from Fibrous Membranes Prepared by Emulsion and Suspension Electrospinning.

Preparation and Protein Sustained-release System of Electrospinning Nanofibers

Sustained delivery of vascular endothelial growth factor using a dextran/poly(lactic-co-glycolic acid)-combined microsphere system for therapeutic neovascularization

Ultrafine fibrous membranes by coaxial electrospinning for artificial blood vessel

Dual-delivery of VEGF and PDGF by double-layered electrospun membranes for blood vessel regeneration.

Enhanced Cellular Function of Human Vascular Endothelial Cell on Poly (Ε-Caprolactone)/gelatin Coaxial-Electrospun Scaffold

Controlled Release of Bfgf Loaded into Electrospun Core-Shell Fibrous Membranes for Use in Guided Tissue Regeneration.

Interaction of Dermal Fibroblasts with Electrospun Composite Polymer Scaffolds Prepared from Dextran and Poly Lactide-Co-glycolide

Peptide-modified PELCL Electrospun Membranes for Regulation of Vascular Endothelial Cells.

Enhanced Vascularization in Hybrid PCL/Gelatin Fibrous Scaffolds with Sustained Release of VEGF

Preparation and Performance of Random- and Oriented-Fiber Membranes with Core-Shell Structures Via Coaxial Electrospinning.

Electrospun Membranes of PELCL/PCL-REDV Loading with Mirna-126 for Enhancement of Vascular Endothelial Cell Adhesion and Proliferation

Sustainable release of vancomycin, gentamicin and lidocaine from novel electrospun sandwich-structured PLGA/collagen nanofibrous membranes

Electrospun PELCL Membranes Loaded with QK Peptide for Enhancement of Vascular Endothelial Cell Growth

Antimicrobial Eugenol-Loaded Electrospun Membranes of Poly(ε-Caprolactone)/gelatin Incorporated with REDV for Vascular Graft Applications.

Fabrication of PEI/PLGA nanofibers by coaxial electrospinning

A small-diameter vascular graft immobilized peptides for capturing endothelial colony-forming cells

Fabrication of Core‐sheath Structured Fibers for Model Drug Release and Tissue Engineering by Emulsion Electrospinning

Functional Electrospun Fibrous Scaffolds with Dextran-G-poly(l-lysine)-vapg/microrna-145 to Specially Modulate Vascular SMCs